Moreover, we found an inverse association between the methylation status and the expression levels of SLC22A18. These results have also been corroborated in vitro, in which a DNA methylating agent (ademetionine) changed their pattern of expression in a panel of NSCLC cell lines. The gene discussed is SLC67A1; the disease is non-small cell lung carcinoma.